Ipsita Volety

Ms. Ipsita Volety

Opthalmology, Cancer biology, University of Illinois at Chicago, Chicago, Illinois, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2021 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
KMKrishnaraju Madavaraju
Krishnaraju Madavaraju
RKRaghuram Koganti
Raghuram Koganti
Ipsita VoletyIpsita Volety
Ipsita Volety
TYTejabhiram Yadavalli
Tejabhiram Yadavalli
Deepak ShuklaDeepak Shukla
Deepak Shukla
Herpes simplex virus (HSV) can infect a broad host range and cause mild to life threating infections in humans. The surface glycoproteins of HSV are evolutionarily conserved and show an extraordinary ability to bind more than one receptor on the host cell surface. Following attachment, the virus fuses its lipid envelope with the host cell membrane and releases its nucleocapsid along with tegument proteins into the cytosol. With the help of tegument proteins and host cell factors, the nucleocapsid is then docked into the nuclear pore. The viral double stranded DNA is then released into the host cell’s nucleus. Released viral DNA either replicates rapidly (more commonly in non-neuronal cells) or stays latent inside the nucleus (in sensory neurons). The fusion of the viral envelope with host cell membrane is a key step. Blocking this step can prevent entry of HSV into the host cell and the subsequent interactions that ultimately lead to production of viral progeny and cell death or latency. In this review, we have discussed viral entry mechanisms including the pH-independent as well as pH-dependent endocytic entry, cell to cell spread of HSV and use of viral glycoproteins as an antiviral target.

3 February 2023 in Brain
Verified
Journal Article
Open access
PDF file
ASAashutosh U Shetti
Aashutosh U Shetti
ARAbhirami Ramakrishnan
Abhirami Ramakrishnan
LRLiudmila Romanova
Liudmila Romanova
WLWenping Li
Wenping Li
KVKhanh Vo
Khanh Vo
OLOrly Lazarov
Orly Lazarov
Patients with type 2 diabetes exhibit severe impairments in insulin signaling in the brain and are 5-times more likely to develop Alzheimer’s disease. However, what leads to these impairments is not fully understood. Here, we show reduced expression of endothelial cell caveolin-1 (Cav-1) in the db/db (Leprdb) mouse model of type-2 diabetes. This reduction correlated with alterations in insulin receptor expression and signaling in brain microvessels as well as brain parenchyma. These findings were recapitulated in the brains of endothelial cell-specific Cav-1 knock-out (Tie2Cre; Cav-1fl/fl) mice. Lack of Cav-1 in endothelial cells led to reduced response to insulin as well as reduced insulin uptake. Furthermore, we observed that Cav-1 was necessary for the stabilization of insulin receptors in lipid rafts. Interactome analysis revealed the insulin receptor interacts with Cav-1 and caveolae-associated proteins, insulin degrading enzyme, and the tight junction protein Zonula Occludence-1 in brain endothelial cells. Restoration of Cav-1 in Cav-1 knockout brain endothelial cells rescued insulin receptor expression and localization. Overall, these results suggest that Cav-1 regulates insulin signaling and uptake by brain endothelial cells by regulating IR-a and IR-b localization and function in lipid rafts. Furthermore, depletion of endothelial cell specific Cav-1 and the resulting impairment in insulin transport leads to alteration in insulin signaling in the brain parenchyma of type 2 diabetes.

20 August 2020 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
JHJames Hopkins
James Hopkins
TYTejabhiram Yadavalli
Tejabhiram Yadavalli
RSRahul Suryawanshi
Rahul Suryawanshi
FQFarreh Qatanani
Farreh Qatanani
Ipsita VoletyIpsita Volety
Ipsita Volety
Deepak ShuklaDeepak Shukla
Deepak Shukla
Herpes simplex virus type 2 (HSV-2) causes recurrent lesions in the ano-genital area that may be transmitted through sexual encounters. Nucleoside analogs such as acyclovir (ACV) are currently prescribed clinically to curb this infection. But in some cases, reduced efficacy has been observed due to the emergence of resistance against these drugs. In our previous study, we reported the discovery of a novel anti-HSV-1 small molecule, BX795 which was originally used as an inhibitor of TANK-binding kinase 1 (TBK1). In this study, we report the antiviral efficacy of BX795 on HSV-2 infection in vaginal epithelial cells in vitro at 10 μM and in vivo at 50 μM. Additionally, through biochemical assays in vitro and histopathology in vivo, we show the tolerability of BX795 in vaginal epithelial cells at concentrations as high as 80 μM. Our investigations also revealed that the mechanism of action of BX7959s antiviral activity stems from the reduction of viral protein translation via inhibition of protein kinase B phosphorylation. Finally, using a murine model of vaginal infection, we show that topical therapy using 50 μM BX795 is well tolerated and efficacious in controlling HSV-2 replication.

5 May 2020 in Antiviral Research
Verified
Journal Article
Closed access
AIAqsa Iqbal
Aqsa Iqbal
RSRahul Suryawanshi
Rahul Suryawanshi
TYTejabhiram Yadavalli
Tejabhiram Yadavalli
Ipsita VoletyIpsita Volety
Ipsita Volety
Deepak ShuklaDeepak Shukla
Deepak Shukla

9 October 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
TYTejabhiram Yadavalli
Tejabhiram Yadavalli
Ipsita VoletyIpsita Volety
Ipsita Volety
Deepak ShuklaDeepak Shukla
Deepak Shukla
The use of short oligonucleotide or peptide molecules as target-specific aptamers has recently garnered substantial attention in the field of the detection and treatment of viral infections. Based on their high affinity and high specificity to desired targets, their use is on the rise to replace antibodies for the detection of viruses and viral antigens. Furthermore, aptamers inhibit intracellular viral transcription and translation, in addition to restricting viral entry into host cells. This has opened up a plethora of new targets for the research and development of novel vaccines against viruses. Here, we discuss the advances made in aptamer technology for viral diagnosis and therapy in the past decade.

19 December 2023 in mBio
Verified
Journal Article
Open access
IBIlina Bhattacharya
Ilina Bhattacharya
Ipsita VoletyIpsita Volety
Ipsita Volety
Deepak ShuklaDeepak Shukla
Deepak Shukla
Tank-binding kinase 1 (TBK1) plays a pivotal role as a cellular factor in regulating the immune response against herpes simplex virus type 1 (HSV-1). TBK1’s role in defending against HSV-1 is attributed to its capacity to induce the type I interferon response. Recent discoveries emphasize TBK1’s involvement in the regulation of optineurin (OPTN), an autophagy adaptor protein that plays a direct role in enhancing the antiviral response against HSV-1 through selective autophagy. Intriguingly, OPTN can also reciprocally regulate TBK1, leading to a limited understanding of the precise role of the OPTN-TBK1 axis in HSV-1 infection. In our study, we shed light on the relationship between OPTN and TBK1 in influencing the outcome of HSV-1 infection. Surprisingly, when TBK1 or OPTN was absent in cells, the spread and infectivity of HSV-1 did not align as expected. Furthermore, it was unexpected to note that cells lacking OPTN showed higher interferon expression compared to normal cells, yet they exhibited enhanced viral growth. Our investigations revealed that OPTN can directly degrade HSV-1 through autophagy even in the absence of active TBK1. Interestingly, we identified that another protein, Polo-like kinase 1 (PLK1), can compensate for the absence of TBK1 and trigger autophagy to restrict HSV-1. In summary, our findings highlight that OPTN significantly impacts the outcome of HSV-1 infection, regardless of the conventional antiviral response mediated by TBK1. Additionally, by introducing a new role for PLK1, this research provides valuable insights into the intricate interplay among OPTN, TBK1, and autophagy in shaping the course of HSV-1 infection. IMPORTANCE: Herpes simplex virus type 1 (HSV-1) is globally prevalent, with latent infections observed in up to 80% of the population. The virus is known for subverting host defense mechanisms and infiltrating the nervous system to establish latency in peripheral ganglia. Multiple stressors can reactivate the virus, and recurrent herpes has been linked to vision loss and neurodegeneration. Identifying critical host factors that limit the spread of HSV-1 and the subsequent establishment of latent infection holds the potential to drive new intervention strategies for eradicating the virus. Numerous pieces of evidence underscore the significance of Tank-binding kinase 1 (TBK1) in restricting HSV-1. Reports have also suggested that phosphorylation of optineurin (OPTN) by TBK1 is required for triggering OPTN-mediated autophagy for HSV degradation. This report adds new insights into the roles of OPTN and TBK1 in HSV-1 infection and provides proof of a TBK1-independent HSV-1 restriction through OPTN. It confirms that TBK1 activation can be substituted by PLK1 to provide protection against HSV-1. In contrast, the activation of OPTN is likely an indispensable host defense mechanism for optimal defense against HSV-1.